Pressure Monitoring Market Size Analysis:

The Pressure Monitoring Market was valued at USD 12.74 billion in 2023 and is expected to reach USD 27.07 billion by 2032, growing at a CAGR of 8.75% over the forecast period of 2024-2032. This report underscores the increasing incidence of hypertension and cardiovascular disease as the primary drivers, coupled with regional trends in device adoption and use, especially in aging and health-aware populations. The research contrasts blood pressure drug prescription behavior with the increased desire for self-measurement via wearable and home-based devices. The research also investigates regional healthcare spending on hypertension treatment and monitoring solutions, with a growing emphasis on preventive care. The report discusses the penetration of home-based pressure monitoring devices, aided by consumer demand for convenience and real-time health monitoring. Further, it discusses technological development and AI integration in monitoring systems, which are improving diagnostic accuracy and user experience.

The U.S. Pressure Monitoring Market was valued at USD 3.68 billion in 2023 and is expected to reach USD 7.41 billion by 2032, growing at a CAGR of 8.12% over the forecast period of 2024-2032. In the United States, market growth is driven by a high prevalence of hypertension, high consumer demand for remote monitoring, and positive reimbursement policies favoring digital health adoption among both urban and rural populations.

Pressure Monitoring Market Dynamics

Drivers

  • The increasing global prevalence of chronic conditions such as hypertension, cardiovascular diseases, and respiratory disorders.

As per the World Health Organization, approximately 1.28 billion adults aged between 30 and 79 years across the globe have hypertension, two-thirds of whom reside in low- and middle-income nations. This rising burden drives the need for ongoing and reliable pressure measurement in both home and clinical settings. Concurrently, advances in monitoring technology, namely, wearable sensors, Bluetooth cuffs, and AI-based monitoring systems, are reshaping the ways vital signs are monitored and cared for. These innovations not only ensure greater patient compliance and diagnostic accuracy but also lower the necessity of repeated clinical encounters. Additionally, increased growth in remote patient monitoring (RPM) and digital health platforms has opened up possibilities for wider access to pressure monitoring, particularly in response to the COVID-19 pandemic, which fast-tracked the move toward home care. The increased focus on preventive healthcare, along with increased patient awareness, is also driving market growth. Together, all these factors are compelling healthcare professionals and patients to embrace contemporary pressure monitoring solutions, providing a sound basis for long-term market growth.

Restraints

  • High device costs and lack of reimbursement policies limit widespread adoption.

Despite the increasing demand, the prohibitively expensive nature of sophisticated pressure monitoring devices is a major market growth restraint, especially in resource-constrained healthcare systems. Devices that integrate smart sensors, wireless communication capabilities, and cloud-based storage tend to incorporate higher prices, which are unaffordable for large sections of society. For instance, intelligent blood pressure meters range from USD 50 to USD 150 per unit, which might be unaffordable for low-income families or health care organizations in developing countries. Adding to the problem is the absence of wide-ranging reimbursement policies for home-based blood pressure monitoring devices across most nations. In contrast to insurance-covered, hospital-based monitoring, out-of-pocket costs of personal monitoring devices usually discourage patients from embracing them, particularly for extended periods of use. Second, public health budgets in poor areas are biased toward meeting acute clinical requirements over preventive monitoring technology. The two factors of economic hurdles and unpredictable policy support persist in impeding market penetration, especially in non-urban environments where healthcare facilities are already inadequate. Without broader insurance coverage and cost-reduction strategies, the market may struggle to achieve its full potential despite strong demand indicators.

Opportunities

  • The growing demand for home-based monitoring and AI integration creates significant growth potential.

The growing trend toward home healthcare and personalized medicine provides a huge opportunity for the pressure monitoring market. With the expansion of chronic conditions and aging populations, patients increasingly are choosing home-based care solutions that provide convenience, cost savings, and real-time health tracking. A study by the American Heart Association discovered that home blood pressure self-monitoring enhances patient compliance and treatment efficacy, demonstrating robust clinical justification for these devices. This need is also increased by the quick development of digital health technology. Artificially intelligent pressure monitoring equipment can recognize signs of impending health decline, providing predictive feedback and tailored health alerts. For example, AI-based algorithms embedded in wearable monitors are now able to scan patterns and suggest lifestyle or medication changes, minimizing hospitalizations. The intermingling of IoT (Internet of Things), mobile health applications, and cloud connectivity also facilitates remote monitoring and doctor access to current patient information. Governments and private entities alike are increasingly putting money into telehealth infrastructure, developing an enabling environment for smart pressure monitoring devices. It creates an opportunity for diversification of products, innovation, and market outreach in unreached rural and semi-urban regions where conventional care delivery is constrained.

Challenges

  • Data privacy, device calibration issues, and interoperability concerns hinder large-scale deployment.

Although the pressure monitoring market is a strong area for growth, several serious issues persist to hinder its smooth expansion. An important concern is patient confidentiality and data security, especially for cloud-connected and mobile-enabled devices. As pressure monitors become more collecting and transmitting of intimate health information, they can instill cybersecurity risks and non-compliance with data protection policies (e.g., HIPAA or GDPR) that discourage consumers and medical providers alike. Another long-standing challenge is the accuracy and dependability of measurements, particularly in home and wearable devices. Unreliable calibration, user mistakes, and equipment failure can produce misleading readings, incorrect diagnoses, or unsuitable adjustments of treatment. Furthermore, the non-interoperability between brands and health IT systems hinders data aggregation and centralized surveillance, especially in hospital environments based on a common electronic health record (EHR). Disjointed device ecosystems prevent easy remote monitoring and patient management. Regulatory barriers further delay the addition of new actors since medical device approval requires full validation and conformity processes. Overcoming these technological and regulatory constraints needs to occur through standardization, cross-compatibility, and testing to have confidence that pressure monitoring technologies meet their potential for clinical and out-of-clinic environments.

Pressure Monitoring Market Segmentation Analysis

By Product

In 2023, the segment of pulmonary pressure monitors held the largest share in the pressure monitoring market in terms of revenue at 42.5%. The large market share is ascribed to the growing incidence rate of chronic respiratory diseases like pulmonary hypertension and chronic obstructive pulmonary disease (COPD), along with rising ICU admissions that need constant pulmonary pressure monitoring.

On the other hand, the blood pressure monitors segment is likely to exhibit the fastest growth during the forecast period. The rising prevalence of hypertension, enhanced awareness about cardiovascular health, and heightened use of home-based digital monitoring devices are leading the speedy adoption of these devices in developed as well as developing countries.

By End-Use

The hospital segment accounted for the highest revenue share of 45.6% in 2023, mainly because of the large number of critical care procedures and inpatient monitoring that need sophisticated pressure monitoring systems. The presence of skilled professionals and infrastructure to handle complex cases also contributes to the dominance of the segment.

At the same time, ambulatory surgery facilities are poised to be the highest-growing end-use sector. The growing trend toward minimally invasive procedures, reduced patient stays, and cost-efficient delivery of care are generating pressure monitoring device demand in these facilities.

Pressure Monitoring Market Regional Insights

North America was the leading pressure monitoring market in 2023 due to its sophisticated healthcare infrastructure, high disease incidence, and early adoption of new medical technologies. In the United States, close to 47% of adults suffer from hypertension, as per the CDC, which fuels high demand for blood pressure monitoring devices in clinical and homecare environments. The area is also helped by robust reimbursement systems, developed telemedicine infrastructures, and the presence of major market players, further validating its market leadership.

The European pressure monitoring market is expected to have impressive growth throughout the forecast period, driven by increased awareness of chronic illnesses, aging populations, and rising investment in digital health. Germany, the UK, and France are seeing increasing use of home-based pressure monitoring devices as part of preventive care programs. The European Society of Cardiology says cardiovascular disease causes more than 45% of all fatalities in Europe, emphasizing a serious health issue fueling monitoring demand. Besides, favorable government policies supporting remote patient monitoring and the incorporation of health IT systems are driving the environment for expansion. The transition towards value-based healthcare and improved focus on early detection further support the region's growth path.

Pressure Monitoring Market Key Players

  • Philips Healthcare – IntelliVue, SureSigns

  • GE Healthcare – CARESCAPE Monitor, B105/B125 Monitors

  • Welch Allyn, Inc. – Connex Spot Monitor, ProBP 3400

  • Medtronic – INVOS System, Puritan Bennett Ventilator Series

  • Drägerwerk – Infinity Delta Monitor, Vista 120

  • Omron HealthcarePlatinum Blood Pressure Monitor, Evolv

  • A&D Medical Inc. – UA-767 Series, TM-2441

  • SunTech Medical, Inc. – Tango M2, Oscar 2

  • American Diagnostic Corp. – Diagnostix 703, E-Sphyg 3

  • Withings – BPM Connect, BPM Core

  • Briggs Healthcare – HealthSmart Premium Series

  • Rossmax International Ltd. – X5, Z1

  • Spacelabs Healthcare Inc. – Qube, Xprezzon

Recent Developments in the Pressure Monitoring Market

  • In Jan 2025, in a major wearable technology breakthrough, Novosound demonstrated its ultrasound-based blood pressure monitoring at CES 2025 in Las Vegas (January 7–10). The company achieved accuracy comparable to traditional electronic cuffs by miniaturizing its innovative ultrasound technology for wearable devices.

  • In December 2024, Apple reportedly introduced satellite texting capabilities in the Apple Watch Ultra 3, marking a significant enhancement in emergency communication features. This development underscored Apple’s ongoing focus on expanding connectivity and safety features in its wearable devices.

  • In Oct 2024, Dynocardia received a USD 500,000 grant from the NIH's Commercial Readiness Pilot Program to support the late-stage development of its ViTrack cNIBP wrist-worn continuous blood pressure monitoring technology. The funding was aimed at completing verification and validation testing ahead of a premarket submission to the FDA.

Pressure Monitoring Market Report Scope:

Report Attributes Details
Market Size in 2023 USD 12.74 billion       
Market Size by 2032 USD 27.07 billion              
CAGR CAGR of 8.75% From 2024 to 2032
Base Year 2023
Forecast Period 2024-2032
Historical Data 2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product [Blood Pressure Monitors, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors]
• By End-Use [Hospitals, Ambulatory Surgery Centers, Home Care Settings, Others]
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)
Company Profiles Philips Healthcare, GE Healthcare, Welch Allyn, Inc., Medtronic, Drägerwerk, Omron Healthcare, A&D Medical Inc., SunTech Medical, Inc., American Diagnostic Corp., Withings, Briggs Healthcare, Rossmax International Ltd., Spacelabs Healthcare Inc.